chr3-51403261-A-G
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 2P and 7B. PM2BP4_StrongBP6_ModerateBP7
The NM_001387579.1(DCAF1):āc.4347T>Cā(p.Asp1449Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,460,798 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_001387579.1 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DCAF1 | NM_001387579.1 | c.4347T>C | p.Asp1449Asp | synonymous_variant | 24/25 | ENST00000684031.1 | NP_001374508.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DCAF1 | ENST00000684031.1 | c.4347T>C | p.Asp1449Asp | synonymous_variant | 24/25 | NM_001387579.1 | ENSP00000506880.1 | |||
DCAF1 | ENST00000504652.5 | c.4344T>C | p.Asp1448Asp | synonymous_variant | 23/25 | 1 | ENSP00000421724.2 | |||
DCAF1 | ENST00000423656.5 | c.4347T>C | p.Asp1449Asp | synonymous_variant | 23/25 | 5 | ENSP00000393183.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1460798Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 2AN XY: 726576
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Apr 01, 2022 | DCAF1: PM2:Supporting, BP4, BP7 - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.